Epidemiology of atherosclerosis in systemic lupus erythematosus

被引：3

作者：

Urowitz M.B. ^{[1
]}

Nikpour M. ^{[1
]}

Gladman D.D. ^{[1
]}

机构：

[1] Toronto Western Hospital, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto, ON M5T 2S8

来源：

Current Rheumatology Reports | 2009年 / 11卷 / 4期

关键词：

Systemic Lupus Erythematosus; Systemic Lupus Erythematosus Patient; Myocardial Perfusion Imaging; Coronary Event; Traditional Risk Factor;

D O I：

10.1007/s11926-009-0035-z

中图分类号：

学科分类号：

摘要：

Patients with systemic lupus erythematosus (SLE) have a significantly increased risk of atherosclerotic coronary events. Traditional risk factors, such as hypertension and hypercholesterolemia, only partly account for the increased risk of coronary disease in SLE. Other important risk factors include disease and treatmentrelated factors. Novel markers of coronary risk in SLE are being investigated. Several methods have been used to detect subclinical atherosclerosis in patients with SLE. Among these, scintigraphic myocardial perfusion defects have been shown to be predictive of subsequent coronary events, independent of traditional Framingham risk factors. Although the aggressive treatment of reversible risk factors, such as lipids and blood pressure, is advocated by many, no published studies have yet demonstrated a clear reduction in risk of coronary events with this approach. Elucidation of risk factors and preventive strategies for accelerated atherosclerosis in SLE is the subject of ongoing research. © 2009 Current Medicine Group, LLC.

引用

页码：248 / 254

页数：6

共 50 条

[1]

Gladman D.D., Urowitz M.B., Morbidity in systemic lupus erythematosus, J Rheumatol Suppl, 14, SUPPL13, pp. 223-226, (1987)

[2]

Rubin L.A., Urowitz M.B., Gladman D.D., Mortality in systemic lupus erythematosus: The bimodal pattern revisited, Q J Med, 55, pp. 87-98, (1985)

[3]

Urowitz M.B., Bookman A.A., Koehler B.E., Et al., The bimodal mortality pattern of systemic lupus erythematosus, Am J Med, 60, pp. 221-225, (1976)

[4]

Urowitz M.B., Ibanez D., Gladman D.D., Atherosclerotic vascular events in a single large lupus cohort: Prevalence and risk factors, J Rheumatol, 34, pp. 70-75, (2007)

[5]

Manzi S., Meilahn E.N., Rairie J.E., Et al., Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study, Am J Epidemiol, 145, pp. 408-415, (1997)

[6]

Petri M., Perez-Gutthann S., Spence D., Hochberg M.C., Risk factors for coronary artery disease in patients with systemic lupus erythematosus, Am J Med, 93, pp. 513-519, (1992)

[7]

Bruce I.N., Gladman D.D., Urowitz M.B., Premature atherosclerosis in systemic lupus erythematosus, Rheum Dis Clin North Am, 26, pp. 257-278, (2000)

[8]

Adams R.J., Chimowitz M.I., Alpert J.S., Awad I.A., Cerqueria M.D., Fayad P., Taubert K.A., Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: A scientific statement for healthcare professionals from the stroke council and the council on clinical cardiology of the American Heart Association/American Stroke Association, Circulation, 108, 10, pp. 1278-1290, (2003)

[9]

Manzi S., Selzer F., Sutton-Tyrrell K., Fitzgerald S.G., Rairie J.E., Tracy R.P., Kuller L.H., Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus, Arthritis and Rheumatism, 42, 1, pp. 51-60, (1999)

[10]

Roman M.J., Shanker B.-A., Davis A., Lockshin M.D., Sammaritano L., Simantov R., Crow M.K., Schwartz J.E., Paget S.A., Devereux R.B., Salmon J.E., Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus, New England Journal of Medicine, 349, 25, pp. 2399-2406, (2003)

← 1 2 3 4 5 →